The “Clindamycin Phosphate Topical Market” report delivers a comprehensive analysis of the industry, providing valuable insights into its SWOT analysis, growth prospects, and anticipated CAGR. It ...

(RTTNews) - India-based Glenmark Pharmaceuticals Inc.'s USA subsidiary, Thursday announced the launch of Clindamycin Phosphate Foam, 1 percent for the treatment of acne. The company added that ...

1 Glenmark's Clindamycin Phosphate Foam, 1% is only approved for the indication(s) listed in Glenmark's approved label. 2 All brand names and trademarks are the property of their respective owners.

Medtronic plc , a global leader in healthcare technology, today released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, the largest international head-to ...

1 Glenmark’s Clindamycin Phosphate Foam, 1% is only approved for the indication(s) listed in Glenmark’s approved label. 2 All brand names and trademarks are the property of their respective owners. 3 ...

Calix and the old Pilbara Minerals announced on Thursday they would resume work on their first-of-a-kind lithium phosphate processing plant in Western Australia, reversing an October decision to ...

Investing.com -- Glenmark Pharmaceuticals (NSE:GLEN) Inc., USA, has announced the launch of Clindamycin Phosphate Foam, 1%, a product that is bioequivalent and therapeutically equivalent to Evoclin® ...

Clindamycin Phosphate Foam, 1% is indicated for the treatment of acne vulgaris, providing an effective solution for patients seeking topical treatment options. Glenmark’s product offering mirrors the ...

This important study investigates the signaling pathways regulating retinal regeneration. Convincing evidence shows that the sphingosine-1-phosphate (S1P) signaling pathway is inhibited following ...